Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genmab A (GMAB) EBIT (2024 - 2025)

Historic EBIT for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to $58.0 million.

  • Genmab A's EBIT fell 8129.03% to $58.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 956.79%. This contributed to the annual value of $1.1 billion for FY2025, which is 956.79% up from last year.
  • As of Q4 2025, Genmab A's EBIT stood at $58.0 million, which was down 8129.03% from $459.0 million recorded in Q3 2025.
  • Over the past 5 years, Genmab A's EBIT peaked at $459.0 million during Q3 2025, and registered a low of $58.0 million during Q4 2025.